10th October 2019
- 1,200 one-to-one meetings between 100 Irish medical technology companies and 300 global buyers to take place in Dublin
- Irish medtech companies make major announcements on new jobs, new investments, new innovations and new contract wins
- Irish lifesciences sector reports seven per cent growth in 2018
100 Irish medical technology companies will meet with 300 international blue-chip company buyers from 40 countries at Enterprise Ireland’s biennial Med in Ireland event in the RDS in Dublin today.
Med in Ireland is Ireland’s largest medical technologies event showcasing the entire spectrum of the Irish medtech sector and attracting significant interest from the international healthcare community.
The medtech sector in Ireland employs 40,000 people, making Ireland – per capita - the largest medtech employer in the EU. Ireland is one of the leading clusters for medtech product globally, and in 2018, Enterprise Ireland recorded seven per cent export growth to €1.73bn for the lifesciences sector in the twelve-month period.
With over 300 medical technology companies in Ireland - of which 200 are indigenous - the event promotes Ireland as a globally recognised centre of excellence in medtech innovation and technologies.
Med in Ireland 2019 will host a dedicated Medtech Innovation Zone – highlighting what drives the success of Irish companies, from funding to collaboration with the research community. Ireland’s most innovative medtech companies will have the opportunity to demonstrate their new solutions to healthcare delivery to an audience of international buyers.
Speaking at the event, Minister of State for Trade, Employment and Business Pat Breen TD said: “Med in Ireland is a great opportunity for international organisations to engage with Ireland’s existing and emerging leaders across the design, research, development, prototyping, manufacture and marketing of highly innovative medical products and services. In Ireland we present a unique collaborative environment for industry with our vibrant network of highly innovative indigenous companies, large well established FDI multinationals, a continually developing world-class research base and a strong industry-focussed clinical community. We, in Government, know that collaboration is key to delivering innovation in the marketplace – and ultimately, the delivery of sustainable jobs. Through our Project Ireland 2040 and Future Jobs initiatives, we will continue to invest in initiatives through our agencies including Enterprise Ireland to build and strengthen linkages between SMEs, multinational enterprises and our tertiary education institutions.”
Stephen Creaner, Executive Director, Enterprise Ireland said: “Ireland’s world class innovation and research ecosystem are now driving global market penetration for Irish made products and services. Enterprise Ireland has put a focus on facilitating successful partnerships, between indigenous Irish companies, globally reputable healthcare systems and medtech manufacturers.
“Over 1,200 one-to-one company and buyer meetings will take place today. This event will help improve the efficiency of bringing new Irish medtech products and services to market to benefit and improve patient experiences all over the world.”
A number of Irish medtech companies have marked Med in Ireland with major new announcements.
Enterprise Ireland client company Complete Laboratory Solutions (CLS), Ireland’s largest privately-owned contract laboratory, announced the creation of 100 new jobs in Galway over the next two years. CLS currently employs a workforce of 191 who cater for a portfolio of over 600 Irish and international clients.
Following an Enterprise Ireland led International Buyer Visit by Canadian Health Authorities to Ireland last year, Swiftqueue Technologies Limited in partnership with MOBIA Technology Innovations have announced that they have won an open competition to deliver a digital health transformation for hospitals in Newfoundland and Labrador in Canada.
Key Plastics, an engineering company based in Bray, Co. Wicklow and the Rotunda Hospital, Dublin, today announced that they have combined expertise to produce and launch The Umbifunnel - a unique, purpose-designed, cord blood collection device which comprises of a collection funnel and stand. The Umbifunnel removes the need for needles and syringes which eliminates the risk of needle stick injuries and reduces the risk of the blood sample clotting.
Design Partners have announced today, an investment of €500,000 in innovative wearable technologies to deliver next generation medical devices and healthcare experiences.
Serosep Ltd, Ireland’s leading Microbiology Diagnostics company, has confirmed clearance from the US Food and Drug Administration (FDA) for its EntericBio Dx Assay, as well as an agreement on distribution throughout the US.
Nova Leah, a leading cybersecurity solutions provider for medical device manufacturers, announced that it has achieved certification to ISO 9001 in recognition of its commitment to quality management systems and ISO 27001 for information security management.
Ends
For further information, please contact:
Conor O’Donovan, Head of Marketing & Communications, Enterprise Ireland.
01-7272912 / 087 9671342 /conor.odonovan@enterprise-ireland.com
Nicola Corboy, Press & Media Relations, Enterprise Ireland
01 727 2973 / 086 021 0114 / Nicola.corboy@enterprise-ireland.com
Details of company announcements:
Enterprise Ireland client company Complete Laboratory Solutions (CLS), Ireland’s largest privately-owned contract laboratory, announced the creation of 100 new jobs in Galway over the next two years as the MedTech sector continues to grow. CLS provides sampling, analysis and fully trained micro and analytical analysts on contract and onsite managed services to medical device, pharmaceutical, food and environmental clients. CLS currently employs a workforce of 191 who cater for a portfolio of over 600 Irish and international clients.
Following an Enterprise Ireland led International Buyer Visit by Canadian Health Authorities to Ireland last year, Swiftqueue Technologies Limited, in partnership with MOBIA technology Innovations, have announced that they have won an open competition to deliver a digital health transformation for hospitals in Newfoundland and Labrador in Canada. The Eastern Region have a deep focus on providing a digital access to patients for clinical appointments and this project will initially deliver a region wide solution to transform the phlebotomy service for 405,000 patients.
Key Plastics, an engineering company based in Bray, Co. Wicklow and the Rotunda Hospital, Dublin, today announced that they have combined expertise to produce and launch The Umbifunnel - a unique, purpose-designed, cord blood collection device which comprises of a collection funnel and stand. Blood collected from an umbilical cord, post-delivery, is used for common screening and diagnostic tests like blood typing and genetic screening. The Umbifunnel is easy to use, requiring minimal training, removes the need for needles and syringes which eliminates the risk of needle stick injuries, and reduces the risk of the blood sample clotting, making sure that blood samples’ integrity is kept intact.
Design Partners have announced today, an investment of €500,000 in innovative wearable technologies to deliver next generation medical devices and healthcare experiences. Connected wearable devices provide significant opportunities for our MedTech clients in real-time data collection, at home patient monitoring and treatment administration, which in turn reduce the burden on healthcare systems and promote better patient outcomes.
In addition to this, Serosep Ltd, Ireland’s leading Microbiology Diagnostics company, has confirmed that the US Food and Drug Administration (FDA) has cleared the company’s in-vitro multiplexed nucleic acid based test EntericBio® Dx assay for direct, qualitative detection and identification of common enteric pathogens from symptomatic individuals with suspected gastroenteritis. Limerick based Serosep has announced the exclusive distribution of the EntericBio® Dx assay to the US market through Quidel Corporation.
Nova Leah, a leading cybersecurity solutions provider for medical device manufacturers, announced that it has achieved certification to ISO 9001 in recognition of its commitment to quality management systems and ISO 27001 for information security management. The certifications were awarded by the National Standards Authority Ireland (NSAI). Given the company’s overall focus on regulation and compliance, these certifications are both important milestones for the business, especially as it grows its international customer reach.
Back to Department News